Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
- 1 August 1997
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (9), 1380-1387
- https://doi.org/10.1016/s0959-8049(96)00425-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874British Journal of Cancer, 1995
- Single-agent carboplatinum for advanced seminoma a phase II studyCancer, 1993
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Cisplatin combination chemotherapy in advanced seminomaCancer, 1986
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISThe Lancet, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977